| Cover | Mar. 15, 2022 |
| Document Information [Line Items] | |
| Document Type | 8-K |
| Document Period End Date | May 10, 2022 |
| Entity Registrant Name | OPIANT PHARMACEUTICALS, INC. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-38193 |
| Entity Tax Identification Number | 46-4744124 |
| Entity Address, Address Line One | 233 Wilshire Blvd |
| Entity Address, Address Line Two | Suite 400 |
| Entity Address, City or Town | Santa Monica |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 90401 |
| City Area Code | 310 |
| Local Phone Number | 598 5410 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | false |
| Title of 12(b) Security | Common stock, par value $0.001 per share |
| Trading Symbol | OPNT |
| Security Exchange Name | NASDAQ |
| Entity Central Index Key | 0001385508 |
| Amendment Flag | false |
| Former Address | |
| Document Information [Line Items] | |
| Entity Address, Address Line One | 233 Wilshire Blvd |
| Entity Address, Address Line Two | Suite 400 |
| Entity Address, City or Town | Santa Monica |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 90401 |
